Development of Magnetic Resonance (MR) Simulation for Treatment Planning

This study is currently recruiting participants.

Verified by Alberta Cancer Board, December 2007

Sponsored by:	Alberta Cancer Board
Information provided by:	Alberta Cancer Board
ClinicalTrials.gov Identifier:	NCT00314496

Purpose

Retrospectively have access to MR images of patients to develop software that:

segment images
convert MR values to electron density and then
entered into a dose calculation system

The project involves software development of data that is already available. No intervention is made at this point.

Condition
Healthy

U.S. FDA Resources

Study Type:	Observational
Study Design:	Retrospective
Official Title:	Development of MR Simulation for Treatment Planning

Further study details as provided by Alberta Cancer Board:

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:	10
Study Start Date:	September 2005
Estimated Study Completion Date:	October 2008

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

Adult patient with conform histological diagnosis of glioblastoma multiforme signed the consent forms and were willing to go for curative radiation treatment with temozolomide

Criteria

Inclusion Criteria:

Subject 18 years of age and older

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00314496

Contacts

Contact: Gino Fallone, PhD

780-432-8750

ginofall@cancerboard.ab.ca

Locations

Canada, Alberta
Cross Cancer Institute	Recruiting
Edmonton, Alberta, Canada, T6G 1Z2
Contact: Clinical Research Unit 780-989-8152 clinical_trials_cci@cancerboard.ab.ca
Principal Investigator: Gino Fallone, PhD

Sponsors and Collaborators

Alberta Cancer Board

Investigators

Principal Investigator:

Gino Fallone, PhD

Alberta Cancer Board

More Information

Responsible Party:	Alberta Cancer Board ( Gino Fallone )
Study ID Numbers:	EX-0004
Study First Received:	April 11, 2006
Last Updated:	September 22, 2008
ClinicalTrials.gov Identifier:	NCT00314496
Health Authority:	Canada: Health Canada

Study placed in the following topic categories:

Healthy

ClinicalTrials.gov processed this record on January 16, 2009